LNAI is Lunai Bioworks Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.35. Market cap: $11M.
Stock snapshot
| Price | $2.35 |
| Market cap | $11M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About LNAI
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
Related non-dividend companies
Other non-dividend stocks investors research alongside LNAI. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is LNAI's current stock price?
LNAI (Lunai Bioworks Inc.) is currently trading at $2.35.
Does LNAI pay a dividend?
LNAI (Lunai Bioworks Inc.) does not currently pay a regular dividend.
Track LNAI in DiviDrip
Add LNAI to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search LNAI and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.